DXCM vs VSTD · P/E 63, rev $4.03B vs rev $12.8M
DexCom Inc (DXCM) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the DXCM and VSTD stock pages for the full models.
Not investment advice.